LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 1476 | 1349 | 3694 | 0.3652 | -0.0576 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 1476 | 1393 | 3694 | 0.3771 | -0.0378 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 1476 | 1290 | 3694 | 0.3492 | -0.0842 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 1476 | 1195 | 3694 | 0.3235 | -0.1271 |
| SK-BR-3 | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 1476 | 1094 | 3694 | 0.2962 | -0.1726 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1476 | 897 | 3694 | 0.2428 | -0.2615 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1476 | 981 | 3694 | 0.2656 | -0.2236 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1476 | 1152 | 3694 | 0.3119 | -0.1465 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1476 | 1142 | 3694 | 0.3092 | -0.1510 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1476 | 1213 | 3694 | 0.3284 | -0.1189 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1476 | 1057 | 3694 | 0.2861 | -0.1893 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 1 | H20 | 72 | hr | 1476 | 3460 | 3694 | 0.9366 | 0.8944 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 2 | H20 | 72 | hr | 1476 | 3800 | 3694 | 1.0287 | 1.0478 |
| SK-BR-3 | GSK1904529A | 3.33 | uM | LJP6 | 3 | H20 | 72 | hr | 1476 | 3814 | 3694 | 1.0325 | 1.0541 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 1 | N02 | 72 | hr | 1476 | 856 | 3694 | 0.2317 | -0.2799 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 2 | N02 | 72 | hr | 1476 | 1136 | 3694 | 0.3075 | -0.1537 |
| SK-BR-3 | Omipalisib | 3.33 | uM | LJP6 | 3 | N02 | 72 | hr | 1476 | 1153 | 3694 | 0.3121 | -0.1460 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 1 | F20 | 72 | hr | 1476 | 3002 | 3694 | 0.8127 | 0.6879 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 2 | F20 | 72 | hr | 1476 | 2789 | 3694 | 0.7550 | 0.5918 |
| SK-BR-3 | GSK 690693 | 3.33 | uM | LJP5 | 3 | F20 | 72 | hr | 1476 | 2863 | 3694 | 0.7750 | 0.6252 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 1 | B14 | 72 | hr | 1476 | 1180 | 3694 | 0.3194 | -0.1338 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 2 | B14 | 72 | hr | 1476 | 1275 | 3694 | 0.3452 | -0.0910 |
| SK-BR-3 | GW843682X | 3.33 | uM | LJP6 | 3 | B14 | 72 | hr | 1476 | 1129 | 3694 | 0.3056 | -0.1568 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 1 | B08 | 72 | hr | 1476 | 1170 | 3694 | 0.3167 | -0.1383 |
| SK-BR-3 | HG-5-113-01 | 3.33 | uM | LJP5 | 2 | B08 | 72 | hr | 1476 | 1158 | 3694 | 0.3135 | -0.1437 |